Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiology of adult atopic dermatitis
R. Sacotte, Jonathan I. Silverberg
Clinics in Dermatology (2018) Vol. 36, Iss. 5, pp. 595-605
Closed Access | Times Cited: 176

Showing 1-25 of 176 citing articles:

Molecular Mechanisms of Atopic Dermatitis Pathogenesis
Jowita Sroka-Tomaszewska, Magdalena Trzeciak
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4130-4130
Open Access | Times Cited: 327
New treatments in atopic dermatitis
Neha Puar, Raj Chovatiya, Amy S. Paller
Annals of Allergy Asthma & Immunology (2020) Vol. 126, Iss. 1, pp. 21-31
Closed Access | Times Cited: 165
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
Jonathan I. Silverberg, Emma Guttman‐Yassky, Diamant Thaçi, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 12, pp. 1080-1091
Closed Access | Times Cited: 135
Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis
Eric L. Simpson, Melinda Gooderham, Andreas Wollenberg, et al.
JAMA Dermatology (2023) Vol. 159, Iss. 2, pp. 182-182
Open Access | Times Cited: 64
Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials
Andrew Blauvelt, Jacob P. Thyssen, Emma Guttman‐Yassky, et al.
British Journal of Dermatology (2023) Vol. 188, Iss. 6, pp. 740-748
Open Access | Times Cited: 57
Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study
Jingru Tian, Dingyao Zhang, Yi‐Ching Yang, et al.
British Journal of Dermatology (2023) Vol. 190, Iss. 1, pp. 55-61
Closed Access | Times Cited: 46
Deep learning-aided decision support for diagnosis of skin disease across skin tones
Matthew Groh, Omar Badri, Roxana Daneshjou, et al.
Nature Medicine (2024) Vol. 30, Iss. 2, pp. 573-583
Open Access | Times Cited: 38
Depression and psychological distress in US adults with atopic dermatitis
Brian T. Cheng, Jonathan I. Silverberg
Annals of Allergy Asthma & Immunology (2019) Vol. 123, Iss. 2, pp. 179-185
Closed Access | Times Cited: 107
Endophenotypic Variations of Atopic Dermatitis by Age, Race, and Ethnicity
Takashi Nomura, Jianni Wu, Kenji Kabashima, et al.
The Journal of Allergy and Clinical Immunology In Practice (2020) Vol. 8, Iss. 6, pp. 1840-1852
Closed Access | Times Cited: 92
Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis
Benjamin Ungar, Ana B. Pavel, Randall Li, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 147, Iss. 1, pp. 394-397
Closed Access | Times Cited: 89
Reframing racial and ethnic disparities in atopic dermatitis in Black and Latinx populations
Emily Croce, Moise L. Levy, Adewole S. Adamson, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 5, pp. 1104-1111
Open Access | Times Cited: 61
Atopic dermatitis: pathomechanisms and lessons learned from novel systemic therapeutic options
Thomas Bieber, Amy S. Paller, Kenji Kabashima, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 9, pp. 1432-1449
Open Access | Times Cited: 54
Clinical phenotypes of adult atopic dermatitis and related therapies
Cataldo Patruno, Luca Potestio, Maddalena Napolitano
Current Opinion in Allergy and Clinical Immunology (2022) Vol. 22, Iss. 4, pp. 242-249
Closed Access | Times Cited: 50
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
Linda Stein Gold, Diamant Thaçi, Jacob P. Thyssen, et al.
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 4, pp. 595-607
Open Access | Times Cited: 30
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis
Andrew Blauvelt, Emma Guttman‐Yassky, Charles Lynde, et al.
JAMA Dermatology (2024) Vol. 160, Iss. 8, pp. 856-856
Open Access | Times Cited: 7
Personalized medicine—concepts, technologies, and applications in inflammatory skin diseases
Thomas Litman
Apmis (2019) Vol. 127, Iss. 5, pp. 386-424
Open Access | Times Cited: 63
Adult-Onset Atopic Dermatitis: Characteristics and Management
Paras P. Vakharia, Jonathan I. Silverberg
American Journal of Clinical Dermatology (2019) Vol. 20, Iss. 6, pp. 771-779
Closed Access | Times Cited: 62
Erythroderma: a prospective study of 309 patients followed for 12 years in a tertiary center
Denis Miyashiro, José Antônio Sanches
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 53
An update on the prevalence, chronicity, and severity of atopic dermatitis and the associated epidemiological risk factors in the Singapore/Malaysia Chinese young adult population: A detailed description of the Singapore/Malaysia Cross-Sectional Genetics Epidemiology Study (SMCGES) cohort
Jun Jie Lim, Ying Yi Eliza Lim, Jun Yan Ng, et al.
World Allergy Organization Journal (2022) Vol. 15, Iss. 12, pp. 100722-100722
Open Access | Times Cited: 31
Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review
Luciano Ibba, Luigi Gargiulo, Carlo Alberto Vignoli, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 593-604
Open Access | Times Cited: 6
Efficacy of biologics in atopic dermatitis
Jianni Wu, Emma Guttman‐Yassky
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 5, pp. 525-538
Closed Access | Times Cited: 39
Association of Atopic Dermatitis With Bacterial, Fungal, Viral, and Sexually Transmitted Skin Infections
Ziyou Ren, Jonathan I. Silverberg
Dermatitis (2020) Vol. 31, Iss. 2, pp. 157-164
Closed Access | Times Cited: 39
Mesenchymal Stem Cells and Atopic Dermatitis: A Review
Sérgio Ricardo Teixeira Daltro, Cássio Santana Meira, Ivanilson Pimenta Santos, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 39
Dysbiosis of skin microbiota with increased fungal diversity is associated with severity of disease in atopic dermatitis
B. Schmid, Axel Künstner, Anke Fähnrich, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 10, pp. 1811-1819
Open Access | Times Cited: 25
Requirements and expectations of high‐quality biomarkers for atopic dermatitis and psoriasis in 2021—a two‐round Delphi survey among international experts
Stefanie Ziehfreund, Linda Tizek, Nora Hangel, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 9, pp. 1467-1476
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top